The National HIV Nurses Association (NHIVNA) is the leading UK professional association representing nurses in HIV care. Founded in 1998, it is a well-established and highly respected organisation committed to providing excellence in the care of those living with and affected by HIV.
The Association aims to provide an academic and educational forum for the dissemination of original nursing research in the field of HIV/AIDS. In addition, NHIVNA aims to address the communication and support needs of these nurses to assist in the promotion of best practice in the care of people with HIV. The Charity's objects are to advance education amongst members of the nursing profession about good nursing practices and to promote improved standards of nursing care of patients with HIV. In addition, NHIVNA supports research into the promotion of HIV nursing skills and aims to publish the results of such research for the benefit of the public.
The current membership of the Association is almost 350, located across the UK and Ireland. Membership benefits include subscription to the key journal HIV Nursing, the NHIVNA newsletter and free attendance at NHIVNA Study Days. For more details on the benefits of membership and how to join, please go to the Membership page.
Seeking members' views
NHIVNA values its members and seeks to empower them by three means: Research, Education and Support. The Association would be very grateful for members' views on how existing activities can be developed and enhanced. Please send your comments or suggestions to the Secretariat on email@example.com.
Kenyan women can distribute HIV self-test kits to their sexual partners without a significant risk of intimate partner violence
Michael Carter | 4 days ago
The distribution of HIV self-testing kits by women to their sexual partners doesn't increase w......MORE
Treatment with bedaquiline significantly reduces mortality among South African people with XDR- and MDR-TB
Michael Carter | 5 days ago
Bedaquiline-based regimens are associated with large reductions in mortality in people with dr......MORE
Will an HIV vaccine that protected two-thirds of monkeys do the same for humans?
Gus Cairns | 8 days ago
Summary The Lancet last Friday published the 52-week results of APPROACH, an HIV vaccine whose......MORE
PrEP@Home pilot shows monitoring PrEP without clinic visit is feasible and acceptable
Keith Alcorn | 9 days ago
A pilot project, PrEP@Home, reduced clinic visits to one a year and demonstrated that men who ......MORE